Congenital Adrenal Hyperplasia Companies

ID: MRFR/Pharma/3515-HCR

85 Pages

Vikita Thakur

Last Updated: February 16, 2025

Congenital Adrenal Hyperplasia (CAH) is a genetic disorder affecting the adrenal glands and resulting in an impaired production of cortisol and often aldosterone. While there may not be companies exclusively focused on CAH due to its relatively rare nature, pharmaceutical companies, research institutions, and healthcare organizations may be involved in the development of treatments and support for individuals with CAH.

Congenital Adrenal Hyperplasia Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)6.79%

2024 Market Size$ 0.52 Billion

2025 Market Size$ 0.56 Billion

2035 Market Size$ 1.08 Billion

Key Players

Pfizer Inc

Sanofi

AstraZeneca

Novartis AG

Boehringer Ingelheim

Teva Pharmaceutical Industries Ltd

Trends

Increased Focus on Early Diagnosis
Advancements in Treatment Options
Rising Awareness and Education

Opportunities

Increased Research Funding
Regulatory Support for New Therapies
Technological Advancements in Diagnostics

Summary Table of Contents Segmentation Methodology Download PDF

Top Industry Leaders in the Congenital Adrenal Hyperplasia Market

Congenital Adrenal Hyperplasia Key Companies

Latest Congenital Adrenal Hyperplasia Companies Update

Neurocrine Biosciences Phase 3 results for NBT274, a potential first-line oral glucocorticoid replacement therapy for patients with classic CAH, were recently presented at the 2023 Endocrine Society's Annual Meeting. Results showed NBT274 effectively controlled hyperandrogenism with fewer side effects compared to standard treatment.

Millendo Therapeutics Announced positive preliminary data from their Phase 1b/2a clinical trial of MTL-1193, a novel once-daily oral mineralocorticoid receptor agonist for CAH. The study demonstrated good safety and tolerability, paving the way for further development.

Spruce Biosciences Achieved positive interim results from its Phase 2 trial of SPRUCE-718, a gene therapy candidate for CAH. The trial showed SPRUCE-718 could potentially restore cortisol production and reduce dependence on glucocorticoid replacement therapy.

List of Congenital Adrenal Hyperplasia Key Companies in the Market

Neurocrine Biosciences, Inc. (U.S.)
Fusion I.P. plc (U.K.)
Novartis AG (Switerzland)
Mitsubishi Chemical Holdings Corporation (Japan)
Johnson & Johnson (U.S.)
GlaxoSmithKline Plc (U.S.)
Cadila Healthcare (India)
Sanofi (France)
Macleods Pharmaceuticals (India)
GlaxoSmithKline Plc. (U.K.)
Allergan (Ireland), Abbott (U.S.)
Hoffmann-La Roche Ltd. (Switzerland)
Eli Lilly and Company (U.S.)
AstraZeneca Plc. (U.K.)
Merck & Co., Inc. (U.S.)

Customize Report

Certified Researchers

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

“The Automotive 48V ECU Components Procurement Intelligence Study” was a complex project, but the Market Research Future (MRFR) team handled it with quality, agility, and customer-centricity. They delivered all requested data on time and within the agreed scope. The team, including Shubhendra Anand and Rahul Gotadki, was always readily available to clarify questions and swiftly implement necessary adjustments, driving the project to a successful conclusion within a very demanding timeframe.
I would also like to specifically commend Akshay Agarwal for his responsiveness and support at every stage—from our initial inquiry on May 6th through to final delivery on June 18th. His dedication made the entire process seamless.”

Guilherme Gomes Martins Product Management Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Congenital Adrenal Hyperplasia Companies

Top Industry Leaders in the Congenital Adrenal Hyperplasia Market

Related Reports

Customer Stories